Pharmacy retail chain Medplus Health's initial public offer (IPO) was subscribed 70 per cent on the first day of its issue on Monday. The public issue subscribed 1.29 times in the retail category, 0.06 times in qualified institutional buyers (QIB) category and 0.16 times in the NII category.
The three-day offer will conclude on December 15.
The IPO comprises fresh issuance of equity shares worth Rs 600 crore and an offer for sale (OFS) of up to equity shares aggregating up to Rs 798.30 crore by the promoter and existing shareholders. MedPlus has cut the OFS size to Rs 798.30 crore from Rs 1,038.71 crore.
The issue includes a reservation of equity shares worth Rs 5 crore for the company's employees who will receive those shares at a discount of Rs 78 per share to the final issue price.
Investors can bid for a minimum of 18 equity shares and in multiples thereof. At the upper end, one lot of MedPlus shares will cost Rs 14,328.
Proceeds of the fresh issue will be used for funding the working capital requirements of the company's subsidiary, Optival.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
